Obesity exacerbates OA symptoms. While weight loss improves symptoms and reduces synovial inflammation, measured by biomarkers, it may also heighten the risk of excessive bone and cartilage loss, when using specific collagen degradation biomarkers. This study is a post-hoc analysis of data from the CSMC trials with clinicaltrial.gov numbers NCT00704847 (2008-06-24) and NCT00486434 (2007-06-14).
Bay-Jensen et al. (Sat,) studied this question.